IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY. (12th June 2019) - Morschhauser, F.; Flinn, I.W.; Gasiorowski, R.; Illés, Á.; Feugier, P.; Greil, R.; Johnson, N.A.; Larouche, J.; Lugtenburg, P.J.; Patti, C.; Salles, G.; Trněný, M.; et al.